133307-22-9

Basic information

• Product Name: 2-ethyl-1-(5-fluoro-2-nitrophenyl)-4-methyl-1H-imidazole
• Synonyms: 2-ethyl-1-(5-fluoro-2-nitrophenyl)-4-methyl-1H-imidazole
• CAS NO: 133307-22-9
• Molecular Weight: 249.245
• Mol File: 133307-22-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-ethyl-1-(5-fluoro-2-nitrophenyl)-4-methyl-1H-imidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-ethyl-1-(5-fluoro-2-nitrophenyl)-4-methyl-1H-imidazole(133307-22-9)
• EPA Substance Registry System: 2-ethyl-1-(5-fluoro-2-nitrophenyl)-4-methyl-1H-imidazole(133307-22-9)

Safety Data

• Hazardous Substances Data: 133307-22-9(Hazardous Substances Data)

Upstream product

• 446-35-5 2,4-Difluoronitrobenzene 
• 931-36-2 2-ethyl-4-methyl-1H-imidazole 
• 931-36-2 2-ethyl-4-methyl-1H-imidazole 
• 584-08-7 potassium carbonate 

Downstream Products

• 1159695-31-4 2-(2-ethyl-4-methyl-imidazol-1-yl)-4-piperidin-1-yl-nitrobenzene 

Relevant articles and documents

IMIDAZO[5,1-C][1,2,4]BENZOTRIAZINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES

The invention relates to imidazo[5,1-c][1,2,4]benzotriazine derivatives of formula I: which are inhibitors of phosphodiesterase 2 or 10 useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type 2 diabetes, metabolic syndrome, glucose intolerance, and pain.

Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogues

A series of novel imidazoquinoxalinones and their aza analogues were prepared by the cyclization of o-amino(1H-imidazol-1-yl)aryls and heteroaryls with carbonyldiimidazole. The compounds were screened for inhibition of Type I and Type IV phosphodiesterase